Akebia Therapeutics, Inc. - AKBA

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 7/31/2025 10:05:58 PM
EDGAR CIK 0001517022

Buy Breakdown

Total $0

Sell Breakdown

Total $885,909

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
06/30/2025
10b5-1
07/01/2025
Ostrowski Erik
SVP, CFO, CBO & Treasurer
CFO
Sell
-41,314 @ $3.67
($151,622.38)
 503,586 (-7.58%) Direct
06/04/2025
10b5-1
06/05/2025
Malabre Richard C
SVP, Chief Accounting Officer
Officer
Sell
-13,334 @ $3.53
($47,069.02)
 266,914 (-4.76%) Direct
03/03/2025
10b5-1
03/04/2025
Burke Steven Keith
SVP, Chief Medical Officer
Officer
Sell
-7,144 @ $1.83
($13,073.52)
 809,090 (-0.88%) Direct
03/03/2025
10b5-1
03/04/2025
Butler John P.
CEO and President
CEO Director
Sell
-46,409 @ $1.83
($84,928.47)
 2,557,921 (-1.78%) Direct
02/03/2025
10b5-1
02/04/2025
Burke Steven Keith
SVP, Chief Medical Officer
Officer
Sell
-50,506 @ $2.10
($106,062.60)
 816,234 (-5.83%) Direct
02/03/2025
10b5-1
02/04/2025
Butler John P.
CEO and President
CEO Director
Sell
-144,250 @ $2.10
($302,925.00)
 2,604,330 (-5.25%) Direct
02/03/2025
10b5-1
02/04/2025
Grund Nicholas
Chief Commercial Officer
Officer
Sell
-55,621 @ $2.10
($116,804.10)
 442,579 (-11.16%) Direct
02/03/2025
10b5-1
02/04/2025
Malabre Richard C
SVP, Chief Accounting Officer
Officer
Sell
-30,202 @ $2.10
($63,424.20)
 280,248 (-9.73%) Direct